Related Experiment Video
Updated: Jul 2, 2026

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts
Published on: October 9, 2016
Molecular characterization of three novel splicing mutations causing factor V deficiency and analysis of the F5 gene
Claudia Dall'Osso1, Ilaria Guella, Stefano Duga
1Department of Biology and Genetics for Medical Sciences, University of Milan, via Viotti 3/5, 20133 Milan, Italy.
Insights
Three novel splicing mutations in the factor V gene (F5) cause factor V deficiency. These mutations lead to altered F5 mRNA splicing and degradation, impacting bleeding disorder severity.
Area of Science:
- Genetics
- Molecular Biology
- Hematology
Background:
- Factor V deficiency is a rare, autosomal recessive hemorrhagic disorder with variable bleeding severity.
- Understanding the molecular basis of factor V deficiency is crucial for diagnosis and potential therapeutic strategies.
Purpose of the Study:
- To investigate the molecular basis of factor V deficiency in three patients.
- To perform a comprehensive analysis of the factor V gene (F5) splicing pattern.
Main Methods:
- Mutational screening using DNA sequencing.
- Expression of wild-type and mutant F5 mRNA in COS-1 cells.
- Analysis of mRNA splicing and degradation using RT-PCR and sequencing.
Main Results:
- Identified three novel splicing mutations: IVS8+6T>C, IVS21+1G>A, and IVS24+1_+4delGTAG.
- Demonstrated that mutations activate cryptic splice sites or cause exon skipping (F5-Delta 8-mRNA).
- Confirmed nonsense-mediated mRNA decay (NMD) degrades transcripts with premature termination codons (PTCs).
Conclusions:
- Elucidated the functional consequences of three splicing mutations causing factor V deficiency.
- Identified three alternatively spliced F5 transcripts, including physiologically occurring exon-8 skipping.
- Highlighted the role of NMD in regulating F5 mRNA levels.
Background:
Factor V deficiency is a rare autosomal recessive hemorrhagic disorder, associated with bleeding manifestations of variable severity. In the present study, we investigated the molecular basis of factor V deficiency in three patients, and performed a comprehensive analysis of the factor V gene (F5) splicing pattern.
Design And Methods:
Mutational screening was performed by DNA sequencing. Wild-type and mutant F5 mRNA were expressed by transient transfection in COS-1 cells, followed by reverse-transcriptase polymerase chain reaction and sequencing. Real-time reverse-transcriptase polymerase chain reaction was used to evaluate degradation of mRNA carrying premature termination codons.
Results:
Mutational screening identified three hitherto unknown splicing mutations (IVS8+6T>C, IVS21+1G>A, and IVS24+1_+4delGTAG). Production of mutant transcripts in COS-1 cells demonstrated that both IVS21+1G>A and IVS24+1_+4delGTAG cause the activation of cryptic donor splice sites, whereas IVS8+6T>C causes exon-8 skipping (F5-Delta 8-mRNA). Interestingly, F5-Delta 8-mRNA was also detected in wild-type transfected samples, human liver, platelets, and HepG2 cells, demonstrating that F5 exon-8 skipping takes place physiologically. Since F5-Delta 8-mRNA bears a premature termination codons, we investigated whether this transcript is subjected to nonsense-mediated mRNA decay degradation. The results confirmed the involvement of nonsense-mediated mRNA decay in the degradation of F5 PTC(+) mRNA. Moreover, a comprehensive analysis of the F5 splicing pattern led to the identification of two in-frame splicing variants resulting from skipping of exons 3 and 5-6.
Conclusions:
The functional consequences of three splicing mutations leading to FV deficiency were elucidated. Furthermore, we report the identification of three alternatively spliced F5 transcripts.
Related Concept Videos
RNA Splicing
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Point and Frameshift Mutations
Clot Retraction and Fibrinolysis
